1 September 2021
At the meeting of 4 August 2021 the RMA:
Determined Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
fibrosing interstitial lung disease | 85/2021 | 86/2021 |
polycythaemia vera | 87/2021 | 88/2021 |
primary myelofibrosis | 89/2021 | 90/2021 |
essential thrombocythaemia | 91/2021 | 92/2021 |
carpal tunnel syndrome | 93/2021 | 94/2021 |
myeloma | 95/2021 | 96/2021 |
These SOPs revoke the SOPs previously determined for these conditions.
Determined Amendment Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
ischaemic heart disease | 97/2021 | 98/2021 |
Note: Ischaemic heart disease Amendment Statement of Principles No. 98 of 2021 will be published shortly.
The above SOPs take effect from 20 September 2021.
Summary of Changes
Decided to Undertake Consultation regarding:
Condition | Reasons for Decision | Date for Final Decision |
---|---|---|
aortic stenosis | Intention to remove one or more factors | December 2021 |
colorectal adenoma | Intention to remove one or more factors | December 2021 |
Finalised Declarations for:
Condition | Declaration | Reasons for Decision |
---|---|---|
malignant neoplasm of the brain | ||
malignant neoplasm of the prostate |
Completed Investigations
The above determinations and declarations conclude the previously advertised investigations into:
- fibrosing interstitial lung disease
- polycythaemia vera
- primary myelofibrosis
- essential thrombocythaemia
- carpal tunnel syndrome
- myeloma
- ischaemic heart disease (focussed review - psoriasis and psoriatic arthritis)
- malignant neoplasm of the brain (focussed review - exposure to carbamate insecticides and fungicides)
- malignant neoplasm of the prostate (focussed review - asbestos exposure)
New Investigations
Decided to advertise the following investigations:
- chronic myeloid leukaemia
- vaccine-induced thrombotic thrombocytopaenia
- pilonidal sinus (focussed review - prolonged sitting)
The above declaration and investigation notices appear in the Government Notices Gazette of 31 August 2021.